ARCHIVES

OMB reviewing Administration’s Reauthorization Bill; NCI Special Authority Probably Will Remain

This article is from The Cancer Letter archive.

Vol. 14 No. 16 | April 15, 1988

Download PDF Visit The Full Archive

Related Articles

Early ADT Doesn’t Offer Survival Advantage—ASCO

April 27, 2007

In Brief: HEW Opposes Research Contract Peer review; Congressman Blass Inadequate Grant Funds

May 10, 1974

In Brief: New Greg For Surgery Research Approved; Only 30 Bioassay Program Reports Still In Backlog

April 21, 1978

Laertrile Clinical Study Provides Solid Evidence: It Is Useless

May 8, 1981

NCAB Member Pollin Organizes Minority Outreach Effort

January 4, 1991

DOD To Reimburse Care On Clinical Trials In Three-Year Deal

February 9, 1996